Results 211 to 220 of about 7,856,482 (335)
Impact of Clinical and Dosimetric Factors on Pericardial Effusion in Patients With Stage I Esophageal Cancer Treated With Definitive Chemoradiation Therapy [PDF]
Keisuke Tamari +9 more
openalex +1 more source
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou +5 more
wiley +1 more source
2024 impact factor increases again and submissions up ~30. [PDF]
Elliott DB.
europepmc +1 more source
Maternal Hypotension with Regional Anesthesia for Elective Cesarean Delivery: Risk factor and Impact on Neonate Outcome [PDF]
강윤단
openalex +1 more source
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham +21 more
wiley +1 more source
Impact Factor Insights 2025: Analysis of Pakistani Academic Journals. [PDF]
Meo SA, Jawaid SA.
europepmc +1 more source
An Impact Factor for Neuro-Oncology Practice. [PDF]
Taphoorn MJB.
europepmc +1 more source

